DEFINITIVE PROXY STATEMENT

Company

Amneal Pharmaceuticals, Inc.

Filed

March 25, 2026

Period of Report

May 6, 2026

Accession Number

0001308179-26-000143

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →